Effects of empagliflozin in diabetes treatment
Phase 3
- Conditions
- type II Diabetes.Type 2 diabetes mellitus
- Registration Number
- IRCT20191126045505N1
- Lead Sponsor
- Bojnourd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Type 2 diabetic patients who have been diagnosed for at least 6 months and treated at least with two anti-diabetic drugs.
710
BMI= Kg/m245
Exclusion Criteria
EGFR<45
Liver Failure
Type1 diabetes
History of ketosis
History of frequent falls and recurrent infections
Significant renal disease requiring dialysis
Inappropriate drug use
Serious medical conditions such as severe cardiovascular disease such as heart attack or stroke in the last three months
Blood pressure above 180/110 mmHg
Major surgery performed in the last 28 days
Cancer treatment in the past 5 years
Receiving systemic glucocorticoids
Alcohol or substance abuse
Pregnancy and lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method